Negative consequences of blood pressure reduction. Respiratory aspects.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D005730:Ganglionic Blockers / Q000009:adverse effects; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008171:Lung Diseases / Q000139:chemically induced*; D012120:Respiration Disorders / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006830:Hydralazine